Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Products>This Product

Mesenchymal Stem Cell Growth Medium

Product Image
Product Description

Developed for the optimal proliferation of mesenchymal stem cells, allowing them to expand through multiple passages while retaining the ability to differentiate into osteoblasts, adipocytes, and chondrocytes.

- Easy-to-use kit.
- Maintains mesenchymal stem cell pluripotency, normal karyotype, and proliferation capability.
- Certified formulation for culturing a vast majority of mesenchymal stem cells.
- Batch-to-batch consistency.

- All products should be stored in the dark.
- Mesenchymal Stem Cell Basal Medium is stable at 2-8oC for up to one year; other components are stable at -20oC for up to two years.
- Products should be discarded beyond the labeled expiration date.
- Once prepared, the fully supplemented complete medium can be stored for up to one month when stored in the dark at 2-8oC.
- For optimal performance, repeated warm-cooling and freeze-thawing should be avoided.

Quality Control:
Tested for performance on mesenchymal stem cells.  The standard evaluation includes:
1.    Sterility test (bacteria, fungi, and mycoplasma).
2.    pH test.
3.    Osmolality.
4.    Endotoxin.
Intended Use:
Intended for non-human laboratory research use only.

Product Mesenchymal Stem Cell Growth Medium
Company Cyagen Biosciences Inc.
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Cyagen Biosciences Inc.
574 East Weddell Drive, Suite 6 Sunnyvale, CA 94089, U.S.A.

Tel: 800-921-8930
Fax: 408-400-0565

Scientific News
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Nanomedicine Aims to Improve HIV Drug Therapies
New research aims to improve the administration and availability of drug therapies to HIV patients using nanotechnology.
Tumor Markers Reveal Lethality Of Bladder Cancers
Researchers found that detection of certain tumor cells in early stage cancers helps identify high-risk cancers.
Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
Driving Mosquito Evolution to Fight Malaria
Researchers propose insect repellent in conjunction with insecticides to extend current insecticide lifetime.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
ALS Study Reveals Role of RNA-Binding Proteins
The findings are a significant step forward in validating RNA-based therapy as a treatment for ALS.
Observing Direct Inheritance of Gene-Silencing RNA
Research has allowed for the observation of double-stranded RNA molecule being passed from parent to offspring in roundworms.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos